CytomX Therapeutics Inc. (CTMX)
NASDAQ · Healthcare
CytomX Therapeutics Inc. Net Income 2013–2025
CytomX Therapeutics Inc. annual/quarterly net income history and growth rate from 2013 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- CytomX Therapeutics Inc. net income for the quarter ending March 31, 2026 was -18.2 M, a 177.57% decrease year-over-year.
- CytomX Therapeutics Inc. net income for the twelve months ending March 31, 2026 was -9.1 M, a 156.97% decrease year-over-year.
- CytomX Therapeutics Inc. annual net income for 2025 was -17.4 M, a 154.50% decrease from 2024.
- CytomX Therapeutics Inc. annual net income for 2024 was 31.9 M, a 5700.88% decrease from 2023.
- CytomX Therapeutics Inc. annual net income for 2023 was -569000, a 99.43% decrease from 2022.
- CytomX Therapeutics Inc. annual net income for 2022 was -99.3 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
CytomX Therapeutics Inc. Net Income — FAQ
CytomX Therapeutics Inc. (CTMX) net income over the last 13 years — annual and quarterly figures with year-over-year growth and charts.
What is CytomX Therapeutics Inc.'s net income?
CytomX Therapeutics Inc. (CTMX) reported net income of -$17M for fiscal 2025.
Where can I see CTMX's net income history?
The chart and table above show CytomX Therapeutics Inc.'s net income by year and by quarter, including the growth rate.